Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Centre Oscar Lambret
National Cancer Institute (NCI)
Massachusetts General Hospital
Incyte Corporation
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Merck Sharp & Dohme LLC
Mayo Clinic
Stanford University
Grupo Espanol de Tumores Neuroendocrinos
Eli Lilly and Company
Cantargia AB
University of Wisconsin, Madison
Shanghai Zhongshan Hospital
Apexigen America, Inc.
Ludwig Institute for Cancer Research
Masonic Cancer Center, University of Minnesota
Peking Union Medical College Hospital
University of Nebraska
Fudan University
Technical University of Munich
Emory University
Peking Union Medical College Hospital
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
Nektar Therapeutics
Cancer Trials Ireland
Incyte Corporation
SCRI Development Innovations, LLC
Fudan University
Fox Chase Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Fox Chase Cancer Center
AstraZeneca
Gilead Sciences
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Brown University
Celgene
M.D. Anderson Cancer Center
Celgene
Daiichi Sankyo
Chinese University of Hong Kong
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
University of Miami
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology